Analysis of NT-proBNP baseline levels in apollo as a predictor of survival in hereditary transthyretin-mediated (hATTR) amyloidosis
29 May 2018 (08:00 - 12:30)
Organised by:
Abstract
Slides
About the speaker

Hospital Bichat-Claude Bernard, Paris (France)
14 More presentations in this session
Access the full session
The Event
Heart Failure 2018
29 May 2018
08:00 CET
You may be interested in
Congress Session
Congress Presentation
Congress Presentation


